Sign In
Industry
Dr Reddy’s to acquire Mayne Pharma’s US generic products
Dr Reddy's cuts price of cardiovascular drug Cidmus
Breather for Dr Reddy's in anti-trust litigation
DRL launches generic Revlimid drug in US market
Pharma
Dr Reddy's, DNDi join hands to develop new drugs
Dr Reddy's PAT up 108% at Rs. 1,188 crore in Q1
DRL sells its anti-cancer agent rights to Citius
DRL Q1 net profit dips slightly
Bizz Talk
Dr. Reddy stops Avigan study in Kuwait
